Literature DB >> 12061252

Synthesis and pharmacological investigation of some novel 2-phenyl-3-(substituted methyl amino) quinazolin-4(3H)-ones as H1-receptor blockers.

V Alagarsamy1, R Venkatesaperumal, S Vijayakumar, T Angayarkanni, P Pounammal, S Senthilganesh, S Kandeeban.   

Abstract

A series of 2-phenyl-3-(substituted methyl amino) quinazolin-4(3H)-ones were synthesized from 3-amino-2-phenyl quinazolin-4(3H)-one. Their structures were confirmed by spectral data (IR, NMR, and MS) and the purity was ascertained by microanalysis. When tested for H1-receptor blocking activity on isolated guinea pig ileum all the test compounds inhibited histamine induced contraction whereas the compounds 1 (IC50 0.59 x 10(3) ng/ml) and 5 (IC50 0.49 x 10(3) ng/ml) were found to be two fold potent when compared to standard chlorpheniramine maleate. These compounds show less sedation (compound 1 shows 4%, compound 5 shows 7%) than the standard (33%). Hence they could serve as prototype molecules for future development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061252

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  Nano-[Fe3O4@SiO2/N-propyl-1-(thiophen-2-yl)ethanimine][ZnCl2] as a nano magnetite Schiff base complex and heterogeneous catalyst for the synthesis of pyrimido[4,5-b]quinolones.

Authors:  Soheila Esmaili; Ahmad Reza Moosavi-Zare; Ardeshir Khazaei
Journal:  RSC Adv       Date:  2022-02-14       Impact factor: 3.361

2.  Biological effects of a new set 1,2,4-triazolo[1,5-a]quinazolines on heart rate and blood pressure.

Authors:  Rashad Al-Salahi; Kamal-Eldin El-Tahir; Ibrahim Alswaidan; Nabih Lolak; Mohammed Hamidaddin; Mohamed Marzouk
Journal:  Chem Cent J       Date:  2014-01-15       Impact factor: 4.215

3.  Synthesis and antihypertensive screening of new derivatives of quinazolines linked with isoxazole.

Authors:  Mujeeb Ur Rahman; Ankita Rathore; Anees A Siddiqui; Gazala Parveen; M Shahar Yar
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.